NTRK1 and neoplasm: Axl, a TAM (Tyro3/Axl/Mer) family receptor tyrosine kinase (RTK), was recently shown to be highly expressed in radio-resistant tumors, and Axl inhibition in combination with radiotherapy or other anticancer therapies elicited anti-tumor responses [29].